Germany – Pharmaceutical products – Conclusion of non-exclusive discount agreements according to § 130a para. 8 SGB V for the named active substances with conclusion possibility within the framework of the so-called open-house procedure.

The notice concerns the conclusion of non-exclusive discount agreements under § 130a para. 8 SGB V for specific active substances via an open-house procedure. The buyer is a German statutory health insurance fund (GKV-Spitzenverband) serving the insured persons of the participating health insurance funds. There are no specific qualification requirements beyond the legal framework; any pharmaceutical company can participate. The agreements are non-exclusive and open-ended, with no stated contract value or duration.